The remaining genes mutations in NRAS, KIT, PIK3CA, and PGFRA have been observed in NSCLC patients [24–27] and are included in the NGS panel as exploratory predictive biomarkers. The gene discussed is PIK3CA; the disease is non-small cell lung carcinoma.